These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 9514292)

  • 1. Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol.
    Helander A
    Alcohol Clin Exp Res; 1998 Feb; 22(1):111-4. PubMed ID: 9514292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory tests for acute alcohol consumption: results of the WHO/ISBRA Study on State and Trait Markers of Alcohol Use and Dependence.
    Helander A; Eriksson CJ;
    Alcohol Clin Exp Res; 2002 Jul; 26(7):1070-7. PubMed ID: 12170117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of 5-hydroxytryptophol as an alcohol intake marker.
    Helander A; Beck O; Borg S
    Alcohol Alcohol Suppl; 1994; 2():497-502. PubMed ID: 8974374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing ingested ethanol from microbial formation by analysis of urinary 5-hydroxytryptophol and 5-hydroxyindoleacetic acid.
    Helander A; Beck O; Jones AW
    J Forensic Sci; 1995 Jan; 40(1):95-8. PubMed ID: 7533206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary 5-hydroxytryptophol following acute ethanol consumption: clinical evaluation and potential aviation applications.
    Hagan RL; Helander A
    Aviat Space Environ Med; 1997 Jan; 68(1):30-4. PubMed ID: 9006879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of urinary 5-hydroxytryptophol, breath ethanol, and self-report for detection of recent alcohol use during outpatient treatment: a study on methadone patients.
    Helander A; von Wachenfeldt J; Hiltunen A; Beck O; Liljeberg P; Borg S
    Drug Alcohol Depend; 1999 Aug; 56(1):33-8. PubMed ID: 10462090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up of 180 alcoholic patients for up to 7 years after outpatient treatment: impact of alcohol deterrents on outcome.
    Krampe H; Stawicki S; Wagner T; Bartels C; Aust C; Rüther E; Poser W; Ehrenreich H
    Alcohol Clin Exp Res; 2006 Jan; 30(1):86-95. PubMed ID: 16433735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Laboratory testing for recent alcohol consumption: comparison of ethanol, methanol, and 5-hydroxytryptophol.
    Helander A; Beck O; Jones AW
    Clin Chem; 1996 Apr; 42(4):618-24. PubMed ID: 8605681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time course and reproducibility of urinary excretion profiles of ethanol, methanol, and the ratio of serotonin metabolites after intravenous infusion of ethanol.
    Jones AW; Helander A
    Alcohol Clin Exp Res; 1999 Dec; 23(12):1921-6. PubMed ID: 10630611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supervised disulfiram in relapse prevention in alcohol-dependent patients suffering from comorbid borderline personality disorder--a case series.
    Mutschler J; Grosshans M; Koopmann A; Hermann D; Diehl A; Mann K; Kiefer F
    Alcohol Alcohol; 2010; 45(2):146-50. PubMed ID: 20107104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary serotonin and alcohol combined may provoke adverse physiological symptoms due to 5-hydroxytryptophol.
    Helander A; Some M
    Life Sci; 2000 Jul; 67(7):799-806. PubMed ID: 10968409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion patterns of 5-hydroxyindole-3-acetic acid and 5-hydroxytryptophol in various animal species: implications for studies on serotonin metabolism and turnover rate.
    Some M; Helander A
    Life Sci; 2002 Oct; 71(20):2341-9. PubMed ID: 12231396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in serotonin metabolism during treatment with the aldehyde dehydrogenase inhibitors disulfiram and cyanamide.
    Beck O; Helander A; Carlsson S; Borg S
    Pharmacol Toxicol; 1995 Nov; 77(5):323-6. PubMed ID: 8778744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents.
    Niederhofer H; Staffen W
    Drug Alcohol Rev; 2003 Sep; 22(3):295-7. PubMed ID: 15385223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary ethylglucuronide assessment in patients treated with disulfiram: a tool to improve verification of abstention and safety.
    Mutschler J; Grosshans M; Koopmann A; Mann K; Kiefer F; Hermann D
    Clin Neuropharmacol; 2010; 33(6):285-7. PubMed ID: 20975547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disulfiram in severe alcoholism--an open controlled study.
    Ulrichsen J; Nielsen MK; Ulrichsen M
    Nord J Psychiatry; 2010 Dec; 64(6):356-62. PubMed ID: 20297945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disulfiram (antabuse) contracts in treatment of alcoholism.
    O'Farrell TJ; Allen JP; Litten RZ
    NIDA Res Monogr; 1995; 150():65-91. PubMed ID: 8742773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between the urinary alcohol markers EtG, EtS, and GTOL/5-HIAA in a controlled drinking experiment.
    Høiseth G; Bernard JP; Stephanson N; Normann PT; Christophersen AS; Mørland J; Helander A
    Alcohol Alcohol; 2008; 43(2):187-91. PubMed ID: 18230699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary beta-hexosaminidase activity as a marker for the monitoring of sobriety].
    Wehr H; Habrat B; Czartoryska B; Górska D; Woronowicz B
    Psychiatr Pol; 1995; 29(5):689-96. PubMed ID: 8577909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.